Can tonic motor activation be the magical elixir for restless legs syndrome?
作者信息
Andrew Berkowski Joseph, Koo Brian B
机构信息
ReLACS Health, Ann Arbor, MI, USA and.
Department of Neurology, Yale University, New Haven, CT, USA.
出版信息
Sleep. 2023 Oct 11;46(10). doi: 10.1093/sleep/zsad230.
Abstract
摘要
相似文献
1
Can tonic motor activation be the magical elixir for restless legs syndrome?
Sleep. 2023 Oct 11;46(10). doi: 10.1093/sleep/zsad230.
2
I contributes to increased motoneuron excitability in restless legs syndrome.
J Physiol. 2019 Jan;597(2):599-609. doi: 10.1113/JP275341. Epub 2018 Nov 24.
3
Motor performance in patients with restless legs syndrome.
Mov Disord. 2009 Aug 15;24(11):1656-61. doi: 10.1002/mds.22650.
4
[Restless legs syndrome].
Rev Neurol. 2009 Jan 23;48 Suppl 1:S33-6.
5
Sensory profile in primary restless legs syndrome and restless legs syndrome associated with small fibre neuropathy.
Brain. 2011 Apr;134(Pt 4):e167; author reply e168. doi: 10.1093/brain/awq291. Epub 2010 Nov 8.
6
Understanding the pathogenesis of the restless legs syndrome at the level of the dopamine receptor. Are we about to identify the neurochemical deficiency causing schizophrenia?
Med Hypotheses. 1989 Mar;28(3):177-9. doi: 10.1016/0306-9877(89)90048-0.
7
The impact of restless legs syndrome on physical functioning in a community-dwelling population of middle-aged and elderly people.
Sleep Med. 2015 Mar;16(3):399-405. doi: 10.1016/j.sleep.2014.11.013. Epub 2015 Jan 14.
8
Motor system excitability in patients with restless legs syndrome.
Neurology. 1999 Mar 23;52(5):1060-3. doi: 10.1212/wnl.52.5.1060.
9
Restless legs syndrome: an underappreciated and distressing problem for haemodialysis patients.
Intern Med J. 2014 Oct;44(10):1030-3. doi: 10.1111/imj.12559.
10
Restless legs syndrome.
J Am Board Fam Pract. 2001 Sep-Oct;14(5):368-74.
本文引用的文献
1
Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial.
Sleep. 2023 Oct 11;46(10). doi: 10.1093/sleep/zsad190.
2
Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study.
Sleep. 2023 Oct 11;46(10). doi: 10.1093/sleep/zsad188.
3
Long-term Safety, Dose Stability, and Efficacy of Opioids for Patients With Restless Legs Syndrome in the National RLS Opioid Registry.
Neurology. 2023 Apr 4;100(14):e1520-e1528. doi: 10.1212/WNL.0000000000206855. Epub 2023 Jan 25.
4
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
Sleep. 2022 Feb 14;45(2). doi: 10.1093/sleep/zsab212.
5
The Management of Restless Legs Syndrome: An Updated Algorithm.
Mayo Clin Proc. 2021 Jul;96(7):1921-1937. doi: 10.1016/j.mayocp.2020.12.026.
Zotero 插件